< Back to latest news & events

News

Chain of Title – The Importance of Getting It Right

April 2020

Making sure there are no issues with ownership of IP is of crucial importance to any business. The current economic outlook is likely to result in events which require careful management of IP.

Insolvency situations where IP is transferred as a valuable asset, litigation, where businesses try and protect their product and IP rights and sales of IP to raise funds are likely to be more and more common.

In our experience many companies suffer from broken links in the chain of ownership of their IP. Unless ownership of IP has been carefully managed, the problems facing businesses in such events could be costly, and at worse, fatal for a business.

In addition, mistakes often occur when IP rights are transferred as part of a bankruptcy or restructuring situation either because a) proper investigation into the subsistence and ownership of rights has not taken place before the transfer or  b) the rights are not transferred correctly to the new owner

What can go wrong?

Among many other things, the following problems can arise;

  • If a business sale agreement does not contain adequate wording to transfer the IP or there is no follow up assignment, a business purchasing that asset may find themselves having paid for an IP right they don’t actually own. If the previous owner is no longer in existence this can be a difficult situation to remedy.
  • A company who does not own an IP right will not be able to licence, transfer or enforce the right against third parties.  The IP may be an important part of the assets of a company but may not in fact be correctly owned by the company.
  • Where chain of title for a patent or other IP right is not correct, a business may lose  the right to file subsequent applications for the same invention, trade mark or registered design in another jurisdiction.
  • Bad management of records / previous transfers can cause major issues when looking to transfer or licence IP in a short time period.
How Can A Business Address this?
  • Ensuring that on any due diligence a careful review of all IP rights owned by a business is carried out and that the chain of title to these rights is correct. For example – ensuring that any consultants who have carried out work, have transferred such rights to a business, or inventors have transferred their rights in any inventions or that previous transfers are valid
  • Ensuring that where deficiencies occur, that assignments or other remedy to correct title of those rights are carried out
  • Careful document drafting /  management – ensuring that all assignments of IP rights are in the correct form, signed correctly, recorded at the relevant IP office and that the documents are stored in places that are easily accessible. Having documents in hard copy format during the Covid-19 Pandemic could make them difficult to access, so ensuring that where assignments have been executed that electronic copies are available is a good idea.
  • Making sure all transfer documents are reviewed properly to ensure that they are effective in transferring the rights that are intended.

This update was prepared by HGF Senior IP Solicitor Chris Robinson. If you would like further advice on this or any other matter, please contact Chris.  Alternatively, you can contact your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article